The NGPod handheld device and NGPod sensor, which are used to test pH to aid the placement of nasogastric tubes, are being withdrawn from the UK market. The manufacturer has ceased trading in the UK. Users are instructed to quarantine all remaining devices and arrange for their disposal in accordance with regulatory guidance.
Actualités réglementaires24 août 2026•1 min de lecture
NGPod pH Testing Device Withdrawn from UK Market
The NGPod handheld device and sensor for nasogastric tube placement are being withdrawn in the UK after the manufacturer ceased trading; users must quarantine remaining units.
Compilé par l'équipe PharmaCountry · Source : MHRA
Évaluations
(0)
(0)
(0)
(0)
(0)
Plus d'articles
Voir tous les articlesRecherches & Rapports
Global Finished Dosage Manufacturing Landscape 2026
5 oct. 2026
Actualités réglementairesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28 sept. 2026
AnalysePharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28 sept. 2026
Laissez votre note